AN2 Therapeutics Inc <ANTX.O>: Guggenheim initiates coverage with buy rating; target price $9
ANTX•Related News
AI Era net loss turns to USD 4.33 million in Q3 FY26; revenue falls to USD 1.5 million
AERA•
MasTec - Borrows $700 Million Under New Term Loan Agreement On July 20, 2026 - SEC Filing
MTZ•
Four Corners Property Trust acquires Minnesota Burger King property for $1.6 million
FCPT•
Fairmount Healthcare Fund II LP acquires 853,450 Crescent Biopharma shares for $12.38 million
CBIO•
Icahn Enterprises to sell auto-service chain Pep Boys to Mavis for $700 million, WSJ reports
IEP•